Insiders who reported open-market trades in the last 12 months at the companies Tilak Mandadi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Larry Robbins - $352.74M in CVS purchases and sales in the last 12 months
Steven H. Nelson - $1K in CVS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Tilak Mandadi is a corporate insider, tracked as EVP, Chief Exp & Tech Officer of CVS HEALTH Corp (CVS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Tilak Mandadi last file a Form 4?
The most recent primary Form 4 on record is dated 11 May 2026, one of 5 filings going back to 2024.
Has Tilak Mandadi been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($6.23M) across all tracked filings.
Tilak Mandadi is EVP, Chief Exp & Tech Officer of CVS HEALTH Corp (CVS). 5 SEC Form 4 filings on record going back to 2024, most recently on 11 May 2026. Most recent open-market trade: sold $6.23M of CVS on 11 May 2026. Lifetime open-market sales: $6.23M.
Recent transactions
6
The latest 6 SEC Form 4 transactions reported by Tilak Mandadi.
InsiderAlpha's records for Tilak Mandadi go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
